GRENKE AG NA O.N./ DE000A161N30 /
21/06/2024 8:00:14 | Diferencia -0.150 | Volumen | Bid20:30:46 | Ask20:30:46 | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
20.800EUR | -0.72% | 0 Volumen de negocios: 0.000 |
-Volumen de oferta: - | -Tamaño/ Volumen/ Formato de Ask: - | 969.43 millonesEUR | 2.25% | 11.65 |
GlobeNewswire
16:17
TUESDAY DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Akero Therapeutics, Inc. Investors...
GlobeNewswire
16:11
ROSEN, A TOP RANKED LAW FIRM, Encourages Altimmune, Inc. Investors to Secure Counsel Before Importan...
GlobeNewswire
16:00
SPR® Therapeutics Recognized as a Top Workplace in Northeast Ohio for the Third Year in a Row
GlobeNewswire
15:50
ENPH INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Enphase Energy, Inc. Investors ...
GlobeNewswire
15:48
PATH INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that UiPath, Inc. Investors with ...
GlobeNewswire
15:45
Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Class Action...
GlobeNewswire
15:00
ROSEN, A LEADING LAW FIRM, Encourages Enphase Energy, Inc. Investors to Secure Counsel Before Import...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página